DrugPatentWatch Database Preview
Alvogen Company Profile
» See Plans and Pricing
What is the competitive landscape for ALVOGEN, and when can generic versions of ALVOGEN drugs launch?
ALVOGEN has forty-nine approved drugs.
There is one US patent protecting ALVOGEN drugs.
There is one patent family member on ALVOGEN drugs in one country and one hundred and fifty-seven supplementary protection certificates in sixteen countries.
Summary for Alvogen
| International Patents: | 1 |
| US Patents: | 1 |
| Tradenames: | 43 |
| Ingredients: | 43 |
| NDAs: | 49 |
| Patent Litigation for Alvogen: | See patent lawsuits for Alvogen |
| PTAB Cases with Alvogen as petitioner: | See PTAB cases with Alvogen as petitioner |
Drugs and US Patents for Alvogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 202677-003 | Mar 8, 2016 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Alvogen | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-003 | Apr 21, 1993 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Alvogen | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 202677-002 | Jul 26, 2012 | AA | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alvogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alvogen | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-003 | Apr 21, 1993 | 5,264,446 | Start Trial |
| Alvogen | SPECTAZOLE | econazole nitrate | CREAM;TOPICAL | 018751-001 | Dec 23, 1982 | 3,717,655 | Start Trial |
| Alvogen | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-001 | Apr 21, 1993 | 5,264,446 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ALVOGEN drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 450 mg | ➤ Subscribe | 2013-02-28 |
International Patents for Alvogen Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2008038155 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alvogen Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1304992 | CR 2013 00053 | Denmark | Start Trial | PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322 |
| 2932970 | 1890039-9 | Sweden | Start Trial | PRODUCT NAME: DOLUTEGRAVIR SODIUM + RILPIVIRINE HYDROCHLORIDE; REG. NO/DATE: EU/1/18/1282 20180518 |
| 0584952 | 99C0004 | Belgium | Start Trial | PRODUCT NAME: ESTRADIOL, HEMIHYDRATE, NORETHISTERONE, ACETATE; NAT. REGISTRATION NO/DATE: NL 23753 19981210; FIRST REGISTRATION: SE - 14 007 19980306 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
